JBIO
Jade Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.92
+0.06 ▲ +0.43%
🌙 3월 13일 5:50 PM ET (한국 3/14 06:50)
$14.19
+0.27 ▲ +1.94%
| Index | RUT | P/E | - | EPS (ttm) | -5.45 | Insider Own | 17.37% | Shs Outstand | 0.05B | Perf Week | -0.93% |
| Market Cap | 0.69B | Forward P/E | - | EPS next Y | -2.61% | Insider Trans | - | Shs Float | 0.04B | Perf Month | -7.57% |
| Enterprise Value | 0.35B | PEG | - | EPS next Q | -0.47 | Inst Own | 85.78% | Short Float | 3.83% | Perf Quarter | 3.19% |
| Income | -0.09B | P/S | - | EPS this Y | 34.93% | Inst Trans | 42.65% | Short Ratio | 4.87 | Perf Half Y | 79.38% |
| Sales | 0.00B | P/B | 2.06 | EPS next 5Y | 10.43% | ROA | -42.67% | Short Interest | 1.56M | Perf YTD | -9.79% |
| Book/sh | 6.74 | P/C | 2.04 | EPS past 3/5Y | 61.94% 21.92% | ROE | -44.88% | 52W High | -21.4% ($17.71) | Perf Year | 54.12% |
| Cash/sh | 6.82 | P/FCF | - | Sales past 3/5Y | - | ROIC | -27.54% | 52W Low | 112.03% ($6.57) | Perf 3Y | -82.69% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 93.63% | Gross Margin | - | Volatility(W/M) | 6.55% 8.03% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 21.09 | EPS Q/Q | 90.12% | Profit Margin | - | RSI (14) | 44.62 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 21.09 | Sales Q/Q | - | SMA20 | -2.2% ($14.23) | Beta | 0.9 | Target Price | $25.62 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -5.03% ($14.66) | Rel Volume | 0.65 | Prev Close | $13.86 |
| Employees | 55 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 6.41% - | SMA200 | 27.83% ($10.89) | Avg Volume(3M) | 0.32M | Price | $13.92 |
| IPO | 2021/6/30 | Option/Short | Yes/Yes | Trades | 3129 | Volume | 208,927 | Change | 0.43% |
뉴스 로딩 중...